ClearPoint Neuro announced FDA clearance and first-in-human cases using the ClearPoint 2.2 Software with integrated Maestro Brain Modeling, and also the publication of a key validation study for its ClearPoint Maestro Brain Model in the peer-reviewed journal NeuroImage.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLPT:
- ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo
- EU MDR certifies ClearPoint Neuro manual SmartTwist Hand Drill and MR Drill Kit
- ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
- ClearPoint Neuro announces FDA clearance for SmartFrame OR system
- ClearPoint Neuro sees FDA clearance and launch SmartFrame OR in 2024
